• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM; INTRODUCER, CATHETER Back to Search Results
Catalog Number D138502
Device Problems Material Separation (1562); Device-Device Incompatibility (2919)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/09/2023
Event Type  malfunction  
Event Description
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium and the physician noticed that when he flushed the vizigo¿ sheath, it would leak fluid.The physician attempted to advance a catheter through the sheath and was met with resistance.They then attempted to pass a guidewire through the sheath and were met with resistance again.Upon inspection, the biosense webster inc.(bwi) representative noticed the white gasket on the vizigo¿ sheath had been dislodged.The gasket (white circular disc) in the hub was dislodged and obstructing catheters from entering the body.It remained inside the hub until after the case when the physician used more force inserting a catheter with everything outside of the body to determine the cause of the obstruction.The cap/hub remained intact and did not detach from the sheath.No air entered the patient's body.No blood was lost as a result of this.Upon replacing the vizigo¿, the issue was resolved, and the procedure continued.
 
Manufacturer Narrative
The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
The device evaluation was completed on 06-oct-2023.It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium and the physician noticed that when he flushed the vizigo¿ sheath, it would leak fluid.The physician attempted to advance a catheter through the sheath and was met with resistance.They then attempted to pass a guidewire through the sheath and were met with resistance again.Upon inspection, the biosense webster inc.(bwi) representative noticed the white gasket on the vizigo¿ sheath had been dislodged.The gasket (white circular disc) in the hub was dislodged and obstructing catheters from entering the body.It remained inside the hub until after the case when the physician used more force inserting a catheter with everything outside of the body to determine the cause of the obstruction.The cap/hub remained intact and did not detach from the sheath.No air entered the patient's body.No blood was lost as a result of this.Upon replacing the vizigo¿, the issue was resolved, and the procedure continued.Device evaluation details: a picture was received for evaluation following biosense webster's procedures.According to the picture provided by the customer, the hemostatic valve was dislodged from the hub component, and it was observed outside the hub.The product was returned to biosense webster (bwi) for evaluation.Visual inspection and microscopic examination of the returned device were performed following bwi procedures.Visual analysis revealed that the hemostatic valve was dislodged inside of hub component.Microscopic examination of the hemostatic valve surface showed stress marks on the outer diameter.The damage observed could be related to the incorrect insertion of the dilator into the sheath causing the dislodgment of the valve; the stress marks and physical damage observed suggest that excessive force or manipulation was applied; however, this could not be conclusively determined.A device history review was performed for the finished device 00002366 number, and no internal actions related to the complaint were found during the review.The issues reported by the customer were confirmed.The valve issue could be related to the resistance issue reported by the customer.The odp (optimal device performance guide) contains the following caution: always insert a dilator straight into the center of the sheath¿s valve to prevent damage to the valve.Do not insert a dilator at an angle, as damage to the sheath valve may occur.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.H6.Investigation findings code of "appropriate term/code not available" represents photo/video analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (IRVINE)
33 technology drive
irvine CA 92618
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17687270
MDR Text Key322721662
Report Number2029046-2023-01996
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberD138502
Device Lot Number00002366
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/30/2023
Is the Reporter a Health Professional? No
Date Manufacturer Received10/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ABBOTT BRK TRANSSEPTAL NEEDLE
-
-